Long-term record of people living with Wilson's disease
Follows people with Wilson's disease through their regular clinic visits over time.
Key facts
- Who runs it
- Orphalan
- Where
- Belgium, France, Germany, Poland, Saudi Arabia, Spain, and United Kingdom16 sites in 7 countriesChoose a country to see its sites
- Trial code
- Registry title
- International Wilson's Disease Patient Registry (iWilson Registry)
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 29 Jun 2022
- Expected to end
- Dec 2027
- Type of study
- Observational
- Record updated
- 11 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people diagnosed with Wilson's disease, including people without symptoms yet. It is a registry that collects data from routine clinic visits.
- Age
- 12 years and older
- Sex
- All sexes
- Disease stage
- Any person diagnosed with Wilson's disease, including those without symptoms and those with other illnesses.
- Earlier treatment
- Any treatment is allowed, including prescribed, homeopathic or traditional therapies. People who have had no treatment can also join.
Main reasons for not taking part
- The person or their legal guardian does not give written consent
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patient is able to provide, and has provided, written informed consent/assent
- Written documentation has been obtained in accordance with the relevant country and local privacy requirements, where applicable, including:; For US sites: Authorization for Use and Release of Health Research Study Information; For EU sites: Data Protection Consent
- All patients diagnosed with WD including pre-symptomatic individuals and individuals with co-morbidities/diagnoses
- Any treatments including prescribed and homeopathic/traditional therapies or naive patients on no therapy
Who cannot take part
- Refusal of informed consent by either patient or their legally acceptable guardian
This trial has no sites in United States.
It has sites in 7 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Longitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected from the diagnostic evaluation and any relevant past medical history and a summary of WD medication history.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- International Wilson's Disease Patient Registry (iWilson Registry)
- Plain-language title
- Long-term record of people living with Wilson's diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 11 August 2026